Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$847,450
-2.9%
Shares
Shares Volume: 29,977 Shares
Average Share Price: $28.27
INSIDER
Kintz Samuel
PRESIDENT AND CEO (Director)
reported on Oct 10 2024
traded on Oct 8 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,003,816 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $296,331.47 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 91 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $894,625.09 |
| COMPANY PREVIOUS TRADES |